JF Forbes
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Genetics top 0.5%
- Estrogen and related hormone effects
- BRCA gene mutations in cancer
Papers in
-
- Breast Cancer Treatment Studies 16
- Oncology 14
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 4
- Cancer Risks and Factors 3
- Cancer survivorship and care 2
- Co-authors
- J Cuzick (3 shared papers)M Baum (1 shared paper)Joanna Houghton (1 shared paper)Tarek Sahmoud (1 shared paper)J.G.M. Klijn (1 shared paper)Aman U. Budzar (1 shared paper)Anthony Howell (5 shared papers)Simon Cawthorn (3 shared papers)
- Journals
- Cancer Research (9 papers)The Lancet (3 papers)Journal of Clinical Oncology (2 papers)The Breast (2 papers)Annals of Oncology (2 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
JF Forbes
24 papers receiving 2.9k citations
JF Forbes's Hit Papers
Peers
Comparison fields: 5 of 95
- Cancer Research 1.4k
- Genetics 1.9k
- Oncology 1.7k
- Orthopedics and Sports Medicine 164
- Internal Medicine 69
Countries citing papers authored by JF Forbes
This map shows the geographic impact of JF Forbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JF Forbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JF Forbes more than expected).
Fields of papers citing papers by JF Forbes
This network shows the impact of papers produced by JF Forbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JF Forbes. The network helps show where JF Forbes may publish in the future.
Co-authors
The 25 scholars most cited alongside JF Forbes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial Hit paper breakdown → | 2002 | 1461 |
| 2 | First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial Hit paper breakdown → | 2002 | 533 |
| 3 | 2007 | 371 | |
| 4 | 1996 | 147 | |
| 5 | 2009 | 133 | |
| 6 | 2011 | 65 | |
| 7 | 2008 | 50 | |
| 8 | 1997 | 38 | |
| 9 | 2013 | 33 | |
| 10 | 1998 | 33 | |
| 11 | 2009 | 30 | |
| 12 | 2009 | 25 | |
| 13 | 2010 | 11 | |
| 14 | 2006 | 10 | |
| 15 | 2009 | 10 | |
| 16 | 1980 | 7 | |
| 17 | 2011 | 6 | |
| 18 | 2014 | 5 | |
| 19 | 2019 | 4 | |
| 20 | 1993 | 2 |
About JF Forbes
JF Forbes is a scholar working on Cancer Research, Oncology, Genetics, Pulmonary and Respiratory Medicine and Pharmacology, having authored 26 papers that have together received 3.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (16 papers), Estrogen and related hormone effects (11 papers), Advanced Breast Cancer Therapies (8 papers), Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (4 papers), Cancer Risks and Factors (3 papers), Growth Hormone and Insulin-like Growth Factors (2 papers) and Cancer survivorship and care (2 papers). The work is most often cited by research in Cancer Research (1.4k citations), Genetics (1.9k citations), Oncology (1.7k citations), Orthopedics and Sports Medicine (164 citations) and Internal Medicine (69 citations). JF Forbes has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include J Cuzick, M Baum, Joanna Houghton, Tarek Sahmoud, J.G.M. Klijn, Aman U. Budzar, Anthony Howell, Simon Cawthorn, AS Coates and T.J. Powles. Their work appears in journals such as Cancer Research, The Lancet, Journal of Clinical Oncology, The Breast and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.